The healthcare system's history of unethical practices and ongoing issues has fostered a deep mistrust among minority communities. This mistrust affects everything from routine healthcare appointments to participation in clinical trials. Despite significant efforts to increase diversity,
The collaboration between Abzena and Argonaut Manufacturing Services marks a significant milestone in the biopharmaceutical industry. These two leading Contract Development and Manufacturing Organizations (CDMOs) have embarked on a strategic partnership aimed at offering comprehensive solutions for
Auxilius, a company specializing in Clinical Trial Financial Management (CTFM) software for the biopharma industry, has recently raised $10 million in financing led by SignalFire. With an astounding 800% year-over-year growth in annual recurring revenue (ARR) for 2023, this upsurge underscores the
The biopharma industry stands at the crossroads of innovation and necessity as it leans into the burgeoning field of immunology. With the global immunology market anticipated to grow exponentially in the coming years, reaching numbers second only to oncology, major players and emerging startups
The biopharmaceutical industry is currently experiencing a profound transformation, as companies, both large and small, are compelled to reassess their workforce levels. This sweeping realignment is a result of several factors influencing the sector, including diminished funding opportunities, the
The seamless integration of technology into the fabric of scientific research has brought about a seminal shift in the analytical instrument industry. Key industry players have long recognized that innovation is not just a buzzword but the fundamental driver of growth and efficiency in the lab.
The winds of change are coursing through the corridors of the European Union (EU) institutions as sweeping reforms to pharmaceutical legislation are poised to redefine the biopharmaceutical playing field. Originating from the European Commission's Pharmaceutical Strategy for Europe, these
In the ever-evolving landscape of medical treatments, cell therapy emerges as a vivid illustration of how cutting-edge science can unlock new horizons in healthcare. This article delves into the transformative world of cell therapy, highlighting its current state, potential, and the multifaceted
The biopharmaceutical industry is at a critical juncture, facing the pressing need to incorporate sustainability into its growth and innovation strategies. The rise of artificial intelligence (AI) presents both opportunities and challenges in this quest. While AI has demonstrated a profound ability
The two companies leading the charge in integrating human physiology with machinery, Neuralink and Synchron, have both entered the human clinical trials stage of research and development. Both companies aim to improve and eventually restore patients’ mobility, filling the unmet medical needs of m
